IDiyas

For the Inventor, By the Inventor

Montreal, Canada

Tarek S Mansour

USPTO Granted Patents = 17 

Average Co-Inventor Count = 3.4

ph-index = 11

Forward Citations = 346(Granted Patents)


Company Filing History:

goldMedal15 out of 62 
 
Biochem Pharma Inc.
 patents
silverMedal1 out of 1 
 
Biochem Therapeutics Incorporated
 patent
bronzeMedal1 out of 16 
 
Shire Biochem, Inc.
 patents

Years Active: 1995-2004

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6831174 - Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties (2004-12-14),
2. 6369066 - Substituted 1,3-oxathiolanes with antiviral properties (2002-04-09),
3. 6228860 - Substituted 1,3-oxathiolanes with antiviral properties (2001-05-08),
4. 6175008 - Processes for preparing substituted 1,3-oxathiolanes with antiviral properties (2001-01-16),
5. 6156737 - Use of dideoxy nucleoside analogues in the treatment of viral infections (2000-12-05),
6. 6069250 - Method and compositions for the synthesis of dioxolane nucleosides with (2000-05-30),
7. 5945431 - Cytomegalovirus inhibiting compounds (1999-08-31),
8. 5922867 - Method and compositions for the synthesis of dioxolane nucleosides with (1999-07-13),
9. 5763606 - Stereoselective synthesis of nucleoside analogues using bicyclic (1998-06-09),
10. 5756706 - Processes for the diastereoselective synthesis of nucleoside analogues (1998-05-26),
11. 5744596 - Nucleoside analogues and synthetic intermediates (1998-04-28),
12. 5696254 - Processes for the diastereoselective synthesis of nucleoside analogues (1997-12-09),
13. 5693787 - Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside (1997-12-02),
14. 5684164 - Processes for preparing substituted 1,3-oxathiolanes with antiviral (1997-11-04),
15. 5663320 - Processes for the diastereoselective separation of nucleoside analogue (1997-09-02),

Title: The Innovative Contributions of Tarek S. Mansour

Introduction

Tarek S. Mansour is a prominent inventor based in Montreal, Canada, recognized for his significant contributions to the field of antiviral research. With an impressive portfolio of 17 patents, he has made considerable advancements that have the potential to impact the healthcare industry profoundly.

Latest Patents

Among his latest innovations are patents related to processes for preparing substituted 1,3-oxathiolanes, which exhibit unique antiviral properties. These inventions highlight his focus on developing compounds that could serve as crucial tools in combating viral infections.

Career Highlights

Throughout his career, Tarek has worked with notable organizations such as Biochem Pharma Inc. and Biochem Therapeutics Incorporated. His experience in these companies has allowed him to refine his expertise in pharmaceutical sciences and contribute to pioneering research initiatives in antiviral treatments.

Collaborations

Tarek has collaborated with esteemed colleagues, including Haolun Jin and Allan H. Tse, who have shared his vision for innovation in the pharmaceutical industry. Their combined efforts have been instrumental in fostering a creative and productive research environment.

Conclusion

In summary, Tarek S. Mansour's work exemplifies the spirit of innovation and dedication to advancing healthcare through science. His numerous patents and collaborative efforts showcase his commitment to improving human health and fighting viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…